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CANNABIDIOL ALTERS THE IMMUNE RESPONSE TO PORPHYROMONAS 
GINGIVALIS IN MICE 
 
Shilpa Singh 
August 6, 2018 
 
Background: Porphyromonas gingivalis is an important etiologic agent of chronic 
periodontitis, an infectious disease defined by destruction of supporting tissues of the 
teeth. Marijuana is a risk factor for chronic periodontitis, although underlying 
mechanisms are poorly understood. As phytocannabinoids have been ascribed anti-
inflammatory properties, we hypothesized that cannabidiol exposure would lead to 
altered immune response to P. gingivalis infection facilitating bacterial persistence and, 
subsequently, increased alveolar bone loss in cannabidiol (CBD)-exposed mice. 
 
Methods: P. gingivalis-infected cannabinoid receptor 2 (CB2) knockout and wild type 
C57/Bl6 mice were exposed, or not exposed, to cannabidiol. Oral swabs from mice were 
used to monitor the presence of P. gingivalis by PCR and culture. Skulls were harvested, 
defleshed and stained to analyze the amount of bone loss under microscope. Alveolar 
bone volume and alveolar bone density were also analyzed by using CT. Systemic P. 
gingivalis-specific and total IgG and IgM antibodies were quantified by ELISA. 
Periodontal expression of inflammatory markers – CD14, CD45, MIP-2, MMP-9 and  
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IL-1β was measured in the maxillary gingivae by qPCR.  
 
Results: In our hands oral gavage model appears to be one of repeated transient infection 
with P. gingivalis rather than a persistent colonization model. Although P. gingivalis 
could not be detected in oral swabs, the infection was sufficient to produce an immune 
reaction in gingiva and serum. Cannabidiol suppresses total IgM production in mice. If 
this occurs in humans, it applies that adaptive immune response is less well equipped for 
the arrival of oral pathogens. However, CBD did not affect P. gingivalis specific IgG 
response. CBD significantly reduced the expression of IL-1β, CD45 and CD14 
inflammatory markers in maxillary gingiva in P. gingivalis infected wild type mice but 
not CB2 -/- mice. Deficient immune response to P. gingivalis may lead to its persistence 
and more severe periodontal destruction in cannabis users. This is analogous with in-vitro 
nicotine studies and with clinical studies showing more severe clinical manifestations of 
chronic periodontitis in tobacco smokers. However, our results showed a reduction in 
MMP-9 expression in presence of cannabidiol. This anomaly is hard to explain and does 
not correspond with the findings in cigarette smokers where MMP-9 levels are 
significantly higher. Increased bone loss was hypothesized because we know cannabis 
drives bone loss in animals and humans. This did not happen here. May be because we 
didn’t have persistent infection. However, immune differences between wild type versus 







Conclusion and Practical Implications: The results show that cannabidiol alters the 
immune response of mice infected by P. gingivalis. Further studies aimed at 
understanding the effects of altered immune response in presence of cannabidiol should 
be performed. This is particularly important as prevalence of cannabis smoking is 
currently on the rise, partly due to legalization or decriminalization in increasing 
jurisdictions.  
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CHAPTER 1:  INTRODUCTION 
                            Chronic Periodontitis  
 
Chronic periodontitis predominantly affects adults, but aggressive periodontitis may 
occasionally occur in children. According to data derived from the National Health and 
Nutritional Health Examination Survey, around half of Americans above 30 years of age 
have chronic periodontitis, while 70% of people above 65 years suffer from this disease 
(Eke et al., 2015). Around 65% of people living under federal poverty level suffer from 
periodontitis. Chronic periodontitis is a significant public issue since treatment cost is 
very expensive and affects global adult population (Petersen, Bourgeois, Ogawa, 
Estupinan-Day, & Ndiaye, 2005).  
 
The term ‘periodontal diseases’ encompasses a wide variety of chronic inflammatory 
conditions of the gingiva (or gums, the soft tissue surrounding the teeth), bone and 
ligament (the connective tissue collagen fibers that anchor a tooth to alveolar bone) 
supporting the teeth (Kinane, Stathopoulou, & Papapanou, 2017). Chronic periodontitis is 
classified as generalized chronic periodontitis when it affects >10 of the 32 teeth in the 





Chronic periodontitis is characterized by the manifestation of slow irreversible damage of 
periodontal supporting tissue over time (Agrali & Kuru, 2015). It results in progressive 
attachment and alveolar bone loss leading to premature tooth loss.  
 
Periodontal disease begins with gingivitis, the localized inflammation of the gingiva that 
is initiated by bacteria in the dental plaque, which is a microbial biofilm that forms on the 
teeth and gingiva. Chronic periodontitis occurs when untreated gingivitis progresses to 
gingival recession, loss of bone and ligament, which creates the deep periodontal 
‘pockets’ that are a hallmark of the disease and can eventually lead to tooth loss.  
 
Although gingivitis and chronic periodontitis are initiated and sustained by the microbial 
biofilm of the dental plaque, genetic and environmental host factors influence the rate of 
the disease (Kinane et al., 2017).  Sustenance of chronic periodontitis state also depends 
on host inflammatory reaction to the microbial deposits.  
 
Chronic periodontitis is an infectious disease that occurs because of challenge between 
host response and a dysbiotic oral microbiome. Periodontal diseases may aggravate the 
body's overall inflammatory burden, worsening conditions such as diabetes mellitus and 
atherosclerosis (Khader, Dauod, El-Qaderi, Alkafajei, & Batayha, 2006). Increasing 
evidence indicates periodontitis to be a risk factor for several other systemic diseases 




One of the first immune responses to presence of pathogenic bacteria is inflammation. In 
chronic periodontitis, the pathogen bacteria present in dental plaque lead to activation of 
host immune responses. Inflammation is stimulated by chemical factors released by 
injured cells and serves to establish a physical barrier against the spread of infection, and 
to promote healing of any damaged tissue following the clearance of pathogens.  
Inflammatory markers released from immune cells play an important role in initiation of 
innate immune responses, ensuring clearance of pathogen (Stvrtinová, 1995).  
 
CD14 and CD45 are two of the inflammatory markers responsible for initiation of innate 
host immune responses and clearance of pathogen. CD14 is expressed mainly by 
macrophages and neutrophils. It acts as a co receptor (along with Toll Like Receptor 4) 
for detection of bacterial polysaccharide (Kitchens, 2000). CD14 plays a pivotal role in 
TLR4 activation that in turn has a crucial role in activation of innate immunity and 
pathogen recognition (Kirschning & Bauer, 2001). CD45 isoforms are present on all 
nucleated hematopoietic cells. It appears to play a significant role in the ability of 
immune cells to respond to activating stimuli (Donovan & Koretzky, 1993). CD45 
inflammatory marker (leukocyte common antigen) causes increase in cytokine production 
and proliferation of T cells (Hermiston, Xu, & Weiss, 2003). The inflammatory markers 







                           Risk Factors for Chronic Periodontitis 
 
The severity of the periodontal disease is strongly influenced by multiple environmental 
and host risk factors, both modifiable (for example, smoking) and non-modifiable (for 
example, genetic susceptibility) (Kinane et al., 2017). Because of general health 
implications of chronic periodontitis, the CDC has recommended public health programs 
to control the risk factors (Eke et al., 2016). The CDC is currently working with key partner 
organizations such as the American Academy of Periodontology and the American Dental 
Association to improve and sustain surveillance of periodontal disease in the adult U.S. 
population. Epidemiological studies in the United States have shown that low educational 
attainment, income below the federal poverty line, Mexican-American ethnicity and 
African-American ethnicity have all been associated with poor periodontal status in 
multivariable analyses (Eke, Wei, Thornton-Evans, et al., 2016). 
 
Cigarette smoking is a major modifiable risk factor. Smokers have worse periodontal 
status and experience more severe tooth loss than non-smokers (Kinane et al., 2017). A 
study by Zambon JJ et al, examined the association between cigarette smoking and 
subgingival infection with periodontal pathogens to determine if smokers are more likely 
to be infected with certain periodontal pathogens than non-smokers. The researchers 
concluded Porphyromonas gingivalis (P. gingivalis) was also more likely to 
subgingivally infect smokers than non-smokers, hence increasing the risk for occurrence 
of chronic periodontitis (Zambon et al., 1996). Tobacco smoke profoundly influences the 
biological mediators that control bleeding responses to bacterial challenge (Dietrich, 
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Bernimoulin, & Glynn, 2004), promotes oral bacterial dysbiosis (Kumar, 2012), 
compromises innate cell function (Palmer, Wilson, Hasan, & Scott, 2005) and promotes 
protease-antiprotease imbalance (Buduneli & Scott, 2018).  
 
Diabetes mellitus is an established risk factor for periodontitis. Mechanistic studies 
indicate that diabetes mellitus leads to a hyperinflammatory response to the periodontal 
microbiota and impairs resolution of inflammation and repair, which leads to accelerated 
periodontal destruction (Lalla & Papapanou, 2011). In a study, individuals those who 
were long-duration diabetics, especially those over 30 years old, demonstrated more 
attachment loss, bone loss, and deeper probing pocket depths than their nondiabetic 
controls (Grant-Theule, 1996).  
 
Alterations in the host inflammatory response may have a major influence on the 
increased prevalence and severity of periodontal destruction seen in diabetes (Mealey & 
Oates, 2006). The function of immune cells, including neutrophils, monocytes and 
macrophages, is altered in diabetes ("Position Paper: Diabetes and Periodontal Diseases," 
2000). Neutrophil adherence, chemotaxis, and phagocytosis are often impaired, which 
may inhibit bacterial killing in the periodontal pocket and significantly increase 
periodontal destruction (Mealey & Oates, 2006). Impaired host immune response to the 
periodontal pathogenic bacteria lead to increased occurrence of periodontitis in diabetic 





The role of genetics in chronic periodontitis has been investigated in family and twin 
studies. A study in young Indonesian siblings who did not develop severe chronic 
periodontitis despite not receiving regular dental care suggested that genetic factors could 
underlie the less-severe forms of periodontal disease (Pillet, Pozzetto, & Roblin, 2016).  
Intensive research is underway to identify the genes and polymorphisms associated with 
all forms of periodontal disease. Numerous genes are involved in chronic periodontitis, 
and the genotypes of chronic periodontitis might vary across individuals and ethnicities. 
Genetic defects in the recognition and response pathways of the host to identify microbial 
pathogens predispose to either altered microbial colonization or misrecognition of normal 
microbiota leading to dysbiosis and appearance of infectious disease (Nibali, Henderson, 
Sadiq, & Donos, 2014).  
 
Pathogenic bacteria in the biofilm or dental plaque are strongly associated with 
pathogenesis of periodontal diseases. Disease occurs when the balance between the 
microbial biofilm and the host is lost, owing to dysbiosis accompanied with an immune 










                           Cannabis – A Risk Factor for Chronic Periodontitis  
 
Cannabis is a major emerging risk factor for chronic periodontitis. Several human studies 
indicate increased alveolar bone loss in people using cannabis. A ‘cohort study’ by Meier 
et al (2016), showed association between cannabis and periodontal disease in humans. 
Shariff JA (2016), analyzed the data from National Health and Nutrition Examination 
Survey (2011-2012) and showed that frequent recreational cannabis use is associated 
with deeper pocket depths, more clinical attachment loss and higher chances of severe 
periodontitis. Similarly, a cohort study on humans by Brett et al (2014) reported higher 
attachment loss in cannabis smokers. Thomson et al (2008) reported strong association of 
cannabis use with prevalence and incidence of periodontal attachment loss in a 
prospective ‘cohort study’ of young adults. More human studies (example - Zeng et al 
(2014), Jamieson et al (2010)) show similar results.  
 
Cannabis use has been associated with poor oral health, higher caries rates, and higher 
plaque scores. Xerostomia and cannabis stomatitis are reported in frequent cannabis 
users. Cannabis smoking is reported to be associated with a higher incidence of 
premalignant lesions and malignant lesions, including head and neck cancer (Momen-
Heravi & Kang, 2017).   
Although the studies above reported increased risk of periodontitis with the use of 
cannabis, the underlying mechanism is still unclear.  
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                           Porphyromonas gingivalis  
 
Among pathogenic bacteria, P. gingivalis is an important etiologic agent and is found to 
be closely associated with severe forms of periodontal disease (Geng, Liu et al. 2017). P. 
gingivalis is a Gram negative, anaerobic and rod-shaped bacterium. It has been termed as 
a keystone pathogen capable of promoting dysbiosis in the periodontal microbiota in mice. 
P. gingivalis induces chronic periodontitis accompanied by significant alterations in the 
number and community organization of the oral commensal bacteria.  
 
Even in less quantity, P. gingivalis interferes with innate immunity and leads to changes in 
the counts and composition of the oral commensal microbiota. The resulting dysbiotic 
microbial community causes disruption of host–microbial homeostasis, leading to 
inflammatory bone loss (Olsen, Lambris, & Hajishengallis, 2017).  
 
The ability of P. gingivalis to manipulate the host response and promote its chronic 
persistence in the periodontium also benefits from the presence of companion species and 
vice versa in subgingival plaque (Hajishengallis, 2011). Streptococcus gordonii is one of 
the early colonizers that initiate plaque formation and the ability of P. gingivalis to 
specifically recognize and interact with  S. gordonii  is believed to be important 
for P. gingivalis colonization of bacterial plaque (Ng et al., 2016). 
P. gingivalis long fimbriae bind to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
on the streptococcal surface, while its short fimbriae specifically recognize surface proteins 
9 
 
on S. gordonii  and are required for the development of P. gingivalis biofilms on 
streptococcal substrates (Maeda et al., 2004).   
 
 P. gingivalis has several virulence factors many of which are related to subversion of the 
innate immune system. This ability is what often characterizes a successful pathogen, as it 
tends to disable the overall host response while simultaneously enhancing the pathogenicity 
of a polymicrobial community (Olsen & Hajishengallis, 2016).  
 
Retention and growth of P. gingivalis on oral surfaces are facilitated by adhesins including 
fimbriae, hemagglutinins, and proteinases. P. gingivalis fimbriae are a critical factor for 
mediation of interaction of this bacterial organism with host tissues. Fimbriae are critically 
important for bacterial adhesion (Mysak, 2014). P. gingivalis has major and minor fimbriae 
on its cell surface, and both fimbriae contribute to establish the persistent infection and the 
development of periodontitis.  
 
Lipopolysaccharide (LPS) is the major component of the outer membrane of P. gingivalis. 
This biomolecule is a potent virulence factor in periodontitis (Mysak et al., 2014). LPS 
consists of three segments with highly variable and conserved regions. They are a 
phosphorylated glucosamine disaccharide substituted with fatty acids known as lipid A 
which forms the matrix of the outermost membrane leaflet, a highly variable O-
polysaccharide (O-antigen) and a conserved core oligosaccharide that links lipid A to the 
O-polysaccharide. Lipid A section is the ‘bioactive center’ of LPS, responsible for its 
endotoxicity. This is due to the specific and highly sensitive recognition of lipid A by host 
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cells, which subsequently leads to strong immuno-inflammatory response. The LPS 
stimulates the host inflammatory pathway by interacting with the Toll-like Receptor 4 
(TLR 4). P. gingivalis grown in high hemin conditions produces predominantly the isoform 
of LPS with tetra-acylated lipid A structure (P. gingivalis LPS1435/1449). In contrast, under 
low hemin conditions P. gingivalis produces the isoform of LPS with penta-acylated lipid 
A structure (P. gingivalis LPS1690). It has been suggested that shifting LPS into tetra-
acylated lipid A structure may dampen the TLR4-mediated immuno-inflammatory 
response of gingival tissues, allowing the pathogen to invade and proliferate in the gingival 
tissues, thereby leading to progression of periodontal disease (Herath et al., 2013). P. 
gingivalis LPS induces proinflammatory cytokines, such as IL-1β, IL-6, and IL-8, which 
induce periodontal tissue destruction (Mysak et al., 2014). 
 
Gingipains from P. gingivalis are one of the most prominent virulence factors on 
periodontal diseases (Nakayama & Ohara, 2017). Working in concert, gingipains cleave 
not only constituents of periodontal tissue, including the basement membrane structural 
protein collagen, but also protective host proteins such as antibodies and components of 
the complement system. The gingipains exhibit dual functionality in the targeting and 
degradation of complement proteins (Potempa, 2013). P. gingivalis produces three cysteine 
proteases known as gingipains: arginine-gingipain A and B (RgpA and RgpB), and lysine-
gingipain (Kgp), which play an important role in processing/maturation of its own cell 
surface proteins. Gingipains have an adverse effect on healthy tissues via degradation of 
many human proteins including complement system proteins, cytokines, integrins, and 
collagen. Gingipains have effects on host cell functions by disturbance of cellular signal 
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transduction, facilitating long term infection of P. gingivalis by its invasion in gingival 
epithelial cells (Nakayama & Ohara, 2017).  
 
Gingipains of P. gingivalis facilitate the evasion of innate immune response of the host by 
degrading the complement system. The complement system is a major part of the innate 
immune system and is responsible for the host defense against invading microorganisms. 
Complement is the first defense line in the host against invading microbes and is a major 
bridge between innate and adaptive immunity. At high concentrations of gingipains, likely 
to occur when P. gingivalis has established its colonization, the released gingipains can 
inhibit the bactericidal activity of complement by degrading C3 complement component. 
This function can prevent opsonization of complement-sensitive bacteria in the proximity 
of P. gingivalis, thereby promoting mixed-species biofilm development.  
 
Zhang and colleagues established that P. gingivalis can invade osteoblasts and inhibit their 
maturation and mineralization in vitro (Zhang, Swearingen, Ju, Rigney, & Tribble, 2010). 
P. gingivalis LPS, lipids and metabolic products can inhibit the differentiation and 
osteogenesis of osteoblasts and inhibit alveolar bone formation (Zhang, Ju, Rigney, & 
Tribble, 2014). A study by Zhang et al showed that P. gingivalis can invade periodontal 
cells and disturb the homeostasis of osteoblasts and osteoclasts, which contributes to 
alveolar bone loss (Zhang et al., 2014).  
 
Hence, P. gingivalis prevalence can degrade the innate host responses and cause 
destruction of tooth supporting tissues directly through number of virulence factors.  
12 
 
                           Cannabis and Legal Status  
 
As of January 22, 2018, 29 states, the District of Columbia, Guam and Puerto Rico have 
legalized cannabis use for medical purposes (State Medical Marijuana Laws). 
While, seven states and the District of Columbia have legalized the recreational use of 
cannabis. As more states consider legalizing medical or recreational use of cannabis, 
determining the effects of such laws on usage patterns and related outcomes have become 
an important public health priority (Carliner, Brown, Sarvet, & Hasin, 2017).  
 
Among adults, cannabis use has increased considerably over the last 15 years, as have 
adverse health consequences of use, including potential harms to a developing fetus, 
alterations to neurodevelopment when used early in adolescence, risks for a withdrawal 
syndrome and for cannabis use disorder, accidents and fatalities, and impairment in many 
social domains, including education and employment. Among adults, cannabis use is 
generally increasing, and increased prevalence of cannabis use over time has also been 
observed among diverse sociodemographic groups (Carliner et al., 2017).   
 
The medical use of cannabis products to treat disease or improve symptoms remains 
debated, even if the benefits and risks of such medications have been investigated in 
clinical trials on multiple sclerosis, cancer and non-cancer pain, neurodegenerative 




Apart from the legal use of cannabis, the National Institute on Drug Abuse reported that 
cannabis is the most commonly used illegal drug in the United States (2015 National 
Survey on Drug Use and Health). Recreational use has grown and appears to be associated 
with serious mental and physical health problems such as suicidal thoughts and rapid heart 
rate (Debruyne & Le Boisselier, 2015). Cannabis is globally the most widely used illicit 
drug, the World Health Organization estimating that 181.1 million people ages 15-64 years 
used cannabis for nonmedical purposes in the year 2013 (Le Boisselier, Alexandre, Lelong-
Boulouard, & Debruyne, 2017).  
 
Owing to this increased consumption of cannabis, it is imperative to understand the 
relationship of medical and recreational marijuana laws to adult health outcomes. This 














                           Phytocannabinoids  
 
Cannabis, also known as marijuana, is the crushed dried leaves and flowers obtained from 
Cannabis sativa and Cannabis indica plants and contains naturally occurring 
phytocannabinoids. The cannabis flower is comprised of over 100 different cannabinoids, 
the active compounds found within the cannabis plant. Cannabinoids are a collective group 
of compounds that act on cannabinoid receptors. They include plant-derived 
phytocannabinoids, synthetic cannabinoids, and endogenously-derived endocannabinoids. 
 
Cannabinoids work on the endocannabinoid system (ECS) which consists of a series of 
neuromodulatory lipids and receptors located throughout the brain and central and 
peripheral nervous system, which accept endogenous cannabinoids (anandamide, 2-
arachidonoylglycerol) and phytocannabinoids (plant-based) (Babson, Sottile, & Morabito, 
2017).  
 
Cannabinoid receptors, CB1 receptors and CB2 receptors are two main receptors within 
the ECS. The cannabinoid receptors are members of the superfamily of G-protein-coupled 
receptors.  
 
CB1 receptor is most abundant at central and peripheral nerve terminals where its 
activation mediates inhibition of neurotransmitter release. CB1 receptors are mainly 
involved in the central effects of cannabinoids, which include consequences on learning, 
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memory cognition, emotion, movement, sensory perception, and nausea, as well as the 
psychoactive properties associated with cannabinoids (Kelly & Nappe, 2018).  
 
CB2 receptor is predominantly found on immune and inflammatory cells and is likely 
involved in the regulation of both cytokine release and chemotaxis. CB2 receptors affect 
inflammation and immune system regulation (Kelly & Nappe, 2018).  
 
The two most studied endogenous cannabinoids, anandamide (AEA) and 2-
arachidonoylglycerol (2-AG), are synthesized from lipid precursors. Endocannabinoids 
bind to CB1R and CB2R with AEA and 2-AG binding preferentially to CB1R and CB2R, 
respectively. The endogenous cannabinoids, together with their receptors and the enzymes 
involved in their metabolism, form the ECS (Barutta et al., 2018). Endocannabinoids may 
potentially mediate or modulate numerous neurophysiological processes including 
nociception. When activated, these neurotransmitters seem to aid in the regulation of 
several functions, including coordination, pain perception, cognition, gastrointestinal 
motility, heart rate, immune function, and intraocular pressure (Vadivelu, Kai, Kodumudi, 
Sramcik, & Kaye, 2018).   
 
The major phytocannabinoids are delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) 
and cannabinol (CBN) (Barutta, Mastrocola, Bellini, Bruno, & Gruden, 2018). 
THC is the primary psychoactive component of cannabis which is responsible for the 
“high” associated with cannabis use. THC acts on CB1 receptors and yields a biphasic 
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effect such that the impact of THC varies between low and high doses. Because of its 
psychoactive effects, THC is used for recreational purposes.  
 
CBN is the primary product of THC degradation, and there is usually little of it in a fresh 
plant. CBN content increases as THC degrades in storage, and with exposure to light and 
air. It is only mildly psychoactive. Its affinity to the CB2R is higher than for the CB1R 



















                           Cannabinoids and bone health  
 
Mice with CB1 receptor deficiency have high peak bone mass because of an osteoclast 
defect and develop age-related osteoporosis because of impaired bone formation and 
accumulation of bone marrow fat. Mice with CB2 deficiency have relatively normal peak 
bone mass but develop age-related osteoporosis because of increased bone turnover with 
uncoupling of bone resorption from bone formation. Mice with GPR55 deficiency have 
increased bone mass because of a defect in the resorptive activity of osteoclasts, but bone 
formation is unaffected (Idris et al., 2005).  
 
According to a cross sectional study on humans, heavy cannabis users had reduced bone 
density as compared to controls as well as reduced body mass index, high bone turnover, 
and an increase rate of fractures (Sophocleous et al., 2017).  
 
A study performed by Wasserman et al showed femur of mice lacking CB1 or CB2 were 
considerably longer at the end of the rapid growth phase compared to wild-type animals. 
Importantly, THC slowed skeletal elongation of wild type and CB2 knockouts, but not that 
of CB1 deficient mice. This was probably due to a direct effect of THC on hypertrophic 
chondrocytes, because THC inhibited EGC chondrocyte hypertrophy in ex vivo cultures 
and reduced the hypertrophic cell zone thickness of treated animals (Wasserman et al., 
2015). These experimental findings are in line with human studies, reporting that babies 
born to marijuana using mothers have a reduced fetal growth rate, resulting in a reduced 
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birth weight, a shorter stature and a reduced head size at birth ((El Marroun et al., 2009; 
Zuckerman et al., 1989). 
    






















                           Cannabidiol (CBD) and Immunity 
  
CBD is a non-intoxicating constituent of cannabis which acts on CB2R. CBD has been 
shown to counter the effects of THC. Owing to its anti-inflammatory effects, CBD has 
received a lot of attention as a potential therapeutic (Babson et al., 2017).  
 
Strong experimental evidence exists for a role for the endocannabinoid system, in particular 
CB2, in immune modulation. The CB2R is expressed by all immune cells.  
In humans, the highest to lowest CB2-expressing immune cells are: B cells > NK cells > 
macrophages > polymorphonuclear cells > CD4 T cells > CD8 T cells (Galiegue et al., 
1995).  
 
CB2 has been found to play a complex role in regulating migration, proliferation and 
different effector functions of various immune cells (Basu & Dittel, 2011). Both in vitro 











                           Chronic Periodontitis and Immunity  
 
Chronic Periodontitis arises from complex interactions between the host and the 
subgingival dysbiotic microbiota that lead to excessive or dysregulated inflammatory 
responses involving elements of both innate (complement and phagocytes) and adaptive 
(regulatory and effector lymphocytes) immunity (Hajishengallis & Korostoff, 2017).  
Variations in the host response may increase or decrease the susceptibility of different 
individuals to destructive periodontal disease (Benakanakere, Abdolhosseini, Hosur, 
Finoti, & Kinane, 2015).  
 
The host–pathogen interactions that occur at the gingival crevice and periodontal pocket 
site are characterized by neutrophil and granulocyte (polymorphonuclear cell) infiltration, 
which is driven by chemotactic gradients created by the bacteria and the inflammatory 
response and lymphocyte infiltration. The resulting pro-inflammatory agent include 
cytokines such as tumor necrosis factor (TNF), interleukins, interferon-γ (IFNγ) , as well 
as antibodies raised against the biofilm components (Kinane et al., 2017).  
 
Epithelial cells function as a physical barrier against pathogens and elicit innate immune 
responses. Dendritic Langerhans cells within the epithelium take up microbial antigenic 
material and bring it to the lymphoid tissue for presentation to lymphocytes. The 
periodontal lesion is infiltrated with neutrophils, granulocyte (neutrophils are granulocytes) 
and lymphocytes. Neutrophils attempt to engulf and kill bacteria but are overwhelmed by 
the magnitude and chronic persistence of the microbial biofilm. This severe chronic 
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inflammatory response leads to alveolar bone resorption by osteoclasts, and degradation of 
ligament fibers by matrix metalloproteinases and the formation of granulation tissue (Sorsa 
et al., 2016). This pathophysiological situation persists until the tooth is exfoliated or the 
microbial biofilm and granulation tissue are successfully removed therapeutically. 
Thus, host immune response plays an important role in clearance of pathogen and thus in 
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                           Cannabinoids and Chronic Periodontitis  
 
The pathogenesis of chronic periodontitis begins with bacterial accumulation on the hard 
and soft tissues surrounding the tooth (Pihlstrom, Michalowicz, & Johnson, 2005).  To deal 
with the vast array of the continuous microbial challenge present in the supra and sub-
gingival biofilm, the immune system confers a protective immune response to fight off 
invading pathogens. However, destructive immune response can occur when that challenge 
overwhelms the host or is dysregulated during immune reaction (Teng, 2006). Cannabinoid 
receptors, particularly CB2 receptors are present on all immune cells, indicating that they 
can modulate the host immune response in the presence of infection (Basu & Dittel, 2011).  
 
The ability of immune cells to migrate throughout the body is critical for their 
development/maturation as well as for the induction of the immune response during 
infection. CB2 showed a complex regulation pattern with some CB2-ligands promoting 
and others inhibiting chemotaxis. In-vitro studies showed CB2-dependent immune cell 
migration in response to 2-AG and that synthetic CB2-agonists, at least in some 
circumstances, has the capacity to inhibit migration to external stimuli (Basu & Dittel, 
2011). Thus, CBD that acts on CB2 receptor may reduce the immune cell migrations and 
affect the innate host responses in presence of infection. The suppressed innate host 





Cytokines are a large group of proteins that include interleukins (IL), interferons (IFN), 
and growth factors that are produced and secreted by immune cells and play key roles in 
coordinating appropriate immune responses for the resolution of chronic periodontitis 
(Gemmell, Marshall, & Seymour, 1997). The balance between pro-inflammatory and anti-
inflammatory cytokines is crucial for the resolution of the inflammatory reaction in chronic 
periodontitis. Some studies support a role for CB2 in immunosuppression by inhibiting the 
production of pro-inflammatory cytokines and perhaps by enhancing anti-inflammatory 
cytokines ((Correa et al., 2010), (Correa et al., 2009).  Hence, presence of cannabidiol may 
lead to progression of chronic periodontitis in absence of balanced action of cytokines that 
aid in innate host response.  
 
Further, according to an in-vivo study, CB2 receptor deficient mice had significantly lower 
bacterial loads and a significantly higher survival rate as compared to wild type mice. This 
was correlated with lower levels of both the anti-inflammatory cytokine IL-10 and the pro-
inflammatory cytokine IL-6 (Csoka et al., 2009). This suggests that CB2 restricts the 
immune response required for bacterial clearance allowing for the development of a 
detrimental inflammatory response. Persistence of pathogenic bacteria in the oral cavity 
may result in exacerbated periodontal destruction through direct virulence factors.  
 
Some literature studies ((Ossola, Surkin, Mohn, Elverdin, & Fernandez-Solari, 2016),  
(Napimoga et al., 2009)) indicate that cannabinoids can be used to modulate the host 
response and reduce the severity of chronic periodontitis. The basis of this assumption is 
that chronic periodontitis is marked by the presence of pro-inflammatory cytokines and 
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chemokines such as, interleukin 1 beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), 
and monocyte chemoattractant protein-1 (MCP-1). These inflammatory mediators 
propagate the inflammation leading to bone resorption and destruction of periodontal tissue 
(Graves, Oates, & Garlet, 2011). One such study by Abidi et al suggests that CB2 receptor 
ligand agonist downregulated P. gingivalis LPS, IL-1β, and TNF-α stimulated IL-6 and 
MCP-1 levels in primary human periodontal ligament fibroblasts. According to this study, 
the downregulation of inflammatory mediators may be beneficial in treating chronic 
periodontitis (Abidi et al., 2018). To monitor host immune response in presence of 
cannabidiol, we monitored the expression of inflammatory markers – CD14, CD45,  
















                                  Mice Periodontal Disease Model  
 
Animal models and cell cultures have contributed new knowledge in biological sciences, 
including periodontology. Although cultured cells can be used to study physiological 
processes that occur during the pathogenesis of periodontitis, the complex host response 
fundamentally responsible for this disease cannot be reproduced in vitro (Helieh, 2011). 
Experimental animal models are critical tools to investigate mechanisms of periodontal 
pathogenesis and test new therapeutic approaches. Mice constitute the most convenient and 
versatile model for mechanistic immunological research owing to availability of 
genetically defined strains that display specific immunological abnormalities. Hence, mice 
periodontal disease models are used to assess the host response and its effects on the tooth-
supporting tissues (gingiva and bone) under well-controlled conditions (Abe & 
Hajishengallis, 2013).  
 
Mouse models of periodontitis have been productively used to investigate periodontal 
disease mechanisms and to test the potential of novel therapeutic compounds (Baker, 
1994). The ligature model is one of the methods used to induce alveolar bone loss in mice. 
To induce bone loss, a silk ligature is tied typically around maxillary posterior teeth (Abe 
& Hajishengallis, 2013). An important advantage of the ligature-induced periodontitis 
model is that disease can be initiated at a known time with a predictable sequence of events 
culminating in alveolar bone loss within a few days (Bezerra et al., 2000). However, in 
small animals such as mice, the possibility for mechanical trauma by the ligatures, which 




A murine model was developed in which mice are orally infected with P. gingivalis, which 
results in alveolar bone loss (Baker, Evans, & Roopenian, 1994). This model offers many 
benefits over human studies, such as controlled environmental conditions and infection 
levels (Hart et al., 2004). Baker et al. used this system to investigate the genetic control of 
susceptibility to P. gingivalis-induced alveolar bone loss (Baker, Dixon, & Roopenian, 
2000). This model offers the means to determine how genetic variation can influence the 
differential host response to oral infection with P. gingivalis.  
 
Hence, The Baker mouse model of periodontitis has been used to measure alveolar bone 
resorption caused by oral bacterial inoculums as an outcome for the clinical presentation 
of periodontitis in humans (Baker et al., 1994). It was speculated that P. gingivalis initiates 
experimental periodontitis, at least in part, by modifying the endogenous subgingival 
biofilm to acquire enhanced virulence (Kinane & Hajishengallis, 2009). In this model, mice 
naturally develop periodontitis with further increases as a function of age, similar to human 
periodontitis (Helieh, 2011). Therefore, this model is widely used to detect bone loss levels 









                                                   Summary  
 
As discussed above, literature studies suggest that CB2 receptor is responsible for 
downregulating the expression the pro-inflammatory cytokines and enhancing the 
expression of anti-inflammatory cytokines in the inflammatory process of chronic 
periodontitis. This may suggest that cannabinoids may have a protective role in chronic 
periodontitis by inhibiting the inflammatory process. However, ineffective innate immune 
host response to the pathogenic bacteria like P. gingivalis may lead to their persistence in 
the host tissues. P. gingivalis, through its direct virulence factors may lead to destruction 
of periodontal ligament and further reduce the host immune response through its direct 
virulence factors as discussed above. Furthermore, P. gingivalis being determined as 
keystone pathogen in murine model, can convert commensal bacteria to pathogenic strains 
through dysbiosis. This may lead to severe symptoms of chronic periodontitis.  
 
Additionally, this phenomenon can be compared to that seen in smokers who manifest 
higher periodontal bone loss even in absence of overt inflammatory signs clinically (Preber 
& Bergstrom, 1986). Like cannabinoids, smoking also impacts on many components of the 
inflammatory response and on both the innate and adaptive immune responses, which 
results in worse periodontal destruction in them as compared to non-smokers (Knight, Liu, 
Seymour, Faggion, & Cullinan, 2016). The higher level of matrix metalloproteinases in 
smokers than in non-smokers contribute to the worse periodontal tissue destruction (Victor, 
Subramanian, Gnana, & Kolagani, 2014). Similar mechanism may be involved in higher 
periodontal tissue destruction in presence of cannabinoids  
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                                        Hypothesis  
Based on the previous human studies, we hypothesized that cannabidiol (CBD) exposure 
would alter immune response in mice infected with Porphyromonas gingivalis and increase 




                           
 
 
                                      CHAPTER 2: MATERIALS AND METHODS 
 
Porphyromonas gingivalis ATCC 33277 was purchased from the American Type Culture 
Collection (Manassas, VA) and maintained as frozen stocks. P. gingivalis was grown in Gifu 
anaerobic medium (GAM; Nissui Pharmaceutical, Tokyo, Japan). P. gingivalis was grown under 
anaerobic conditions (80% N2, 10% H2, and 10% CO2) at 37
oC. Growth was monitored by tracking 
optical density at a wavelength of 600 nm. Cannabidiol dissolved in methanol was obtained from 
CAYMAN Chemical (Ann Arbor MI, USA). Methanol and Carboxymethyl cellulose (CMC) were 
purchased from Sigma Aldrich Corporation (St. Louis MO, USA). Phosphate Buffered Saline 
(PBS) was purchased from Life Technologies (Grand Island NY, USA).  Isoflurane anesthesia was 
purchased from Henry Schein Animal Health (Dublin OH, USA). RNAlater was purchased from 
Life Technologies (Carlsbad CA). Chelex100 was purchased from Bio-Rad Laboratories 
(Hercules, CA, USA). Methylene Blue and Eosin were obtained from Ricca Chemical Company 
(TX USA). Genomic DNA isolation kit was purchased from Promega (Madison Wisconsin, USA). 
Sheep blood was purchased from Lampire Biological Laboratories (Pipersville PA). PCR primers 
were purchased from Bio-Synthesis Inc. (Lewisville, TX, USA). Immunocal was purchased from 










C57BL6 wild type mice and CB2 receptor deficient mice (CB2-/-), 23 each (males), were purchased 
from the Jackson laboratory. All experimental procedures were performed in accordance with the 
Guidelines of the Institutional Animal Care and Use Committee of University of Louisville. The 
mice received varied in ages by few months. Because of the range of ages, the mice were provided 
with controls age matched to the knock outs. After matching the ages, the mice were distributed 
in groups according to the treatment they received.  
 
 
Figure 1 – Mice groups assignment  
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Both wild type mice and knockout mice were infected with either P. gingivalis in 2% CMC vehicle 
or CMC alone (sham infection) orally. The mice that were infected with P. gingivalis were either 
treated with intraperitoneal injection of cannabidiol or administered vehicle alone. Similarly, the 
mice not infected with P. gingivalis were either treated with intraperitoneal injection of 
cannabidiol or they were just administered vehicle. Three mice from both, wild type and knock 






  Figure 2 Baker Model                                               
     In-vivo mice treatment (Baker Model) 
Baker model was followed to infect the mice with P. gingivalis and treat them with cannabidiol.  
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Day 1 – Upon arrival of mice, mice tails were marked from 1 to 23 in both wildtype and CB2 
knockout mice.  
Day 2 through Day 5 – Mice acclimated to the surrounding environment. No infection or treatment 
was done at this time.  
Day 6 – Mice were treated with intraperitoneal injection of cannabidiol 10 mg/kg with methanol 
as vehicle. Control mice were administered 10 mg/Kg methanol intraperitoneally. The mice were 
administered either cannabidiol or methanol every alternate day till the day of sacrifice.  
Day 7 – Mice were infected (oral gavage) with P. gingivalis (P. gingivalis in PBS and carrier 
CMC) at a concentration of 109 cfu/mouse in 100 ul PBS and 2% CMC. Gavage needle was used 
to infect the mice locally around maxillary molars. To increase the likelihood of infection, mice 
were anaesthetized with 3% isoflurane and then infected with P. gingivalis.  
Sham infected mice received 2% CMC in 100µl PBS.  
The mice were infected with P. gingivalis for a total of five times during the whole process. The 
infection was done after every two days. The sham infected mice were treated the same way except 
that they received just PBS and CMC through oral gavage.  
 
P. gingivalis Detection -  Oral swabs from all the mice were obtained by swabbing the maxillary 
gingiva using on-absorbent mini polyester tipped applicator with flexible aluminum handle. This 
was done to detect the presence of P. gingivalis in the oral cavity to assess the effectiveness P. 
gingivalis infections and to monitor the prevalence of P. gingivalis in the different treatment 
groups.  
Oral swabs were collected for P. gingivalis detection eight days after first infection and then every 




P. gingivalis detection was performed by two methods: 
1. Plate culture. The periodontal microbiota was sampled by swabbing around the teeth of maxilla; 
then some of the swabs were submerged into 300ul anaerobic balanced GAM broth. Bacteria were 
extracted by vortexing for 2 minutes. Serial dilutions (10-2, 10-3, 10-4) of the bacterial suspensions 
were plated onto blood agar plates (100 µl/plate) and CFU were enumerated following anaerobic 
growth for 1 month and examined at 1, 2 and 4 weeks. P. gingivalis was identified by black 
pigmented colonies and gram staining.  
 
2. Standard Polymerase Chain Reaction - Swabs were stored in RNAlater at 4°C. Total DNA was 
extracted from the swabs by using Wizard® Genomic DNA Purification kit (Promega, Cat: 
A1120).  Standard PCR procedure and 2% agarose gel electrophoresis was used to detect the P. 
gingivalis DNA.  
 
 
Day 58 - Mice were euthanized 42 days after the last P. gingivalis infection. Inhalation of carbon 
dioxide was used as the standard method to sacrifice the mice. The flow of Carbon dioxide was to 
1.5 liters per minute. Carbon dioxide flow was maintained for at least 1 minute after respiratory 
arrest. Decease was confirmed by performing cervical dislocation.   
 
Collection of specimen a d in -vitro experiments 
1. Serum  
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Blood was collected from each mouse by cardiac puncture. Sera were stored at - 80°C for later 
assessment. Sera was tested for P. gingivalis exposure by analyzing P. gingivalis specific IgG and 




2. Tissue harvest  
Gingiva of the entire maxilla were excised and was immersed in buffer RLT ( Qiagen). It was 
stored at -80ºC until used for RNA isolation following the manufacturer’s protocol (RNeasy Kit, 
Qiagen, Valencia, CA).  
Real-time quantitative PCR (qPCR) analysis of gingivae was performed to determine cytokine 
mRNA expression of inflammatory markers (CD 45, IL-1B, mip-2, MMP-8,MMP-9 and CD 14).  
 
 Alveolar bone loss evaluation 
Freshly harvested skulls were submerged in deionized water and boiled.  Following defleshing, 
the skulls were immersed overnight in 3% hydrogen peroxide. The skulls were immersed for 1 
min in 1% bleach then washed and air dried. The maxillae were stained with 0.5% eosin for 5 min 
followed by 1% methylene blue for 1 minute (both from Ricca Chemical Company, TX, USA).  
Alveolar bone loss was measured in millimeters at 14 predetermined points on the maxillary 
molars of de-fleshed maxillae as the distance from the cementoenamel junction (CEJ) to the 
alveolar bone crest (ABC). Bone loss was visualized by methylene blue/eosin staining and 
quantified using a Nikon SMZ 800 dissecting microscope (40X, Nikon Instruments Inc., Melville, 
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NY, USA) fitted with a Boeckeler VIA-170K video image marker measurement system (Boeckeler 
Instruments Inc, Tucson, AZ, USA).
 
 
Three-dimensional micro- computed tomographic imaging  
Three-dimensional state of alveolar bone and volumetric alveolar changes were analyzed by using 
micro-computed tomography imaging technique.  
(A) Scanning  
Skyscan micro CT scanner – Skyscan1174v2 and control software Skyscan 114 was used 
to obtain three dimensional images of mice maxillae.  
The following parameters were used for this purpose –  
1. Camera = SHT MR285MC  
2. Image Pixel Size (um) = 9.70 
3. Exposure (ms) = 6000 
4. Rotation step (deg) = 0.500 
5. Rotation used = 180 degrees  
6. Frame Averaging = 3 images were obtained at each rotation  
7. Filter = 0.5 um  
 
(B) Reconstruction  
Scanned images were reconstructed to stack the images together to produce axial, sagittal 
and coronal views. Skyscan NRecon software was used for reconstruction of the images 
obtained by Skyscan scanner (native skyscan data). The native skyscan data is 
automatically detected by NRecon software. The following settings were used –  
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1. Postalignment Applied = 1 
2. Smoothing = 2 
3. Smoothing Kernel = 2  
4. Ring Artifact Correction = 10 
5. Beam Hardening Correction = 10% 
 
(C) Analysis  
Quantitative analysis of the image data set was done for morphometric bone analysis and 
bone density analysis. Bone volumes of the maxillae were measured by choosing furcation 
area of maxillary first molar as volume of interest for all the mice maxillae. In the micro 
Ct software, twenty slices of each reconstructed maxillae image were scrolled through to 
obtain a complex polygonal 3D volume of interest.  This was then used to measure the 
bone volume.  
Calcium hydroxyapatite, phantom materials of known density were used for calibration to 
determine the bone mineral density. The same complex polygonal 3D volume of interest 
(furcation area of maxillary first molar) was used to determine the bone mineral density of 
mice maxillae. 
 
Statistical analysis:  
Data were evaluated by ANOVA (InStat v3.06 program, GraphPad) and differences were 
considered significant at the p < 0.05 level. 
 






                                                   CHAPTER 3: RESULTS 
1. Increased P. gingivalis-specific IgG response was seen in P. gingivalis-infected CB2 
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P g     -       -       +       +      -       -       +      +
C B D   -      +       -        +      -      +       -      +
 
Figure 3.1 - Increased P. gingivalis-specific IgG response in P. gingivalis-infected CB2-/- but not 
Wild type mice. 
The P. gingivalis-specific IgG response was monitored in CB2-/- and Wild Type mice infected, or 
not, with P. gingivalis, in a Baker model of periodontitis at sacrifice. IgG titers were measured in 
sera by ELISA using P. gingivalis (2×107 number of Pg cells per well) and HRP-labeled horse 
anti-mouse IgG (1:5,000).  
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Differences in IgG response between mouse groups (n = 5 per group) were determined by ANOVA 
with post hoc Tukey-Kramer testing (InStat version 3.10; GraphPad Inc, San Diego California 
USA ).  **/*** indicate p < 0.01 and 0.001, respectively. 
 
2. Cannabidiol did not affect the levels of serum IgM specific to P. gingivalis.  
 
  
Figure 3.2 - No significant difference was found in the levels of serum IgM specific to P. gingivalis 
The P. gingivalis- specific IgM response was monitored in CB2-/-
 
and Wild Type mice infected, or 
not, with P. gingivalis, in a Baker model of periodontitis at sacrifice. IgM titers were measured in 
sera by ELISA using P. gingivalis (2×107 number of Pg cells per well) and HRP-labeled horse 
anti-mouse IgG (1:5,000).  
Differences in IgM response between mouse groups (n = 5 per group) were determined by 
ANOVA (InStat version 3.10; GraphPad Inc, San Diego California USA).  
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           3. Cannabidiol did not affect the levels of serum total IgG.  
 
       
Figure 3.3 – No significant difference found in levels of serum total IgG.  
Total IgG response was monitored in CB2
-/-
 and Wild Type mice infected, or not, with P. 
gingivalis, in a Baker model of periodontitis at sacrifice. IgG titers were measured in sera by 
ELISA using HRP-labeled horse anti-mouse IgG (1:5,000).  
Differences in IgG response between mouse groups (n = 5 per group) were determined by ANOVA 











4. Cannabidiol significantly reduced the production of total IgM antibodies in sera of P. 
gingivalis-infected wild-type mice but not in knock-out mice. 
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Figure 3.4 – Cannabidiol significantly reduced the production of total IgM antibodies in sera of P. 
gingivalis infected wild-type mice but not in knock out mice.   
Total IgM response was monitored in CB2-/- and Wild Type mice infected, or not, with P. 
gingivalis, in a Baker model of periodontitis at sacrifice. IgM titers were measured in sera by 
ELISA using HRP-labeled horse anti-mouse IgM (1:5,000).  
Differences in IgM response between mouse groups (n = 5 per group) were determined by 
ANOVA with post hoc Tukey-Kramer testing (InStat version 3.10; GraphPad Inc, San Diego 








5. Cannabidiol significantly reduced the expression of CD45 in maxillary gingiva in P. 
gingivalis-infected wild-type mice but not in knock-out mice. 
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Figure 3.5 - CBD significantly reduced the expression of CD45 in maxillary gingiva in P. gingivalis-
infected wild-type mice but not CB2-/- mice. 
 
Expression of CD45 mRNA, relative to that of glyceraldehyde 3-phosphate dehydrogenase 
(housekeeping gene), in the gingivae of mice was assessed using RT-PCR.  
Differences in expression of maxillary CD45 mRNA in mice groups (n = 5 per group) were 
determined by ANOVA with post hoc Tukey-Kramer testing (InStat version 3.10; GraphPad Inc., 
San Diego California USA).  
* indicate p < 0.05.  
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6.  Cannabidiol significantly reduced the expression of CD14 in maxillary gingiva of wild 
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Figure 3.6 – Cannabidiol significantly reduced the expression of CD 14 mRNA in maxillary gingiva of 
wild type mice infected with P. gingivalis but not in knock out mice.   
 
Expression of CD14 mRNA, relative to that of glyceraldehyde 3-phosphate dehydrogenase 
(housekeeping gene), in the gingivae of mice was assessed using RT-PCR.  
Differences in expression of maxillary CD14 mRNA in mice groups (n = 5 per group) were 
determined by ANOVA with post hoc Tukey-Kramer testing (InStat version 3.10; GraphPad 
Inc., San Diego California USA).  






7.  Cannabidiol significantly reduced the expression of IL- 1β in maxillary gingiva of wild-
type mice treated with P. gingivalis but not in knock-out mice.  
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Figure 3.7 - Cannabidiol significantly reduced the expression of IL-1β in maxillary gingiva of 
wild-type mice treated with P. gingivalis but not in knock out mice.  
 
Expression of IL-1beta mRNA, relative to that of glyceraldehyde 3-phosphate dehydrogenase 
(housekeeping gene), in the gingivae of mice was assessed using RT-PCR.  
Differences in expression of maxillary IL-1beta mRNA in mice groups (n = 5 per group) were 
determined by ANOVA with post hoc Tukey-Kramer testing (InStat version 3.10; GraphPad Inc., 
San Diego California USA).  










8. Cannabidiol significantly reduced the expression of MMP-9 in maxillary gingiva of 
wild type mice infected with P. gingivalis but not in knock-out mice.   
 
    
Figure 3.8 – Cannabidiol significantly reduced the expression of MMP-9 in maxillary gingiva of wild 
type mice infected with P. gingivalis but not in knock out mice.  
 
Expression of MMP-9 mRNA, relative to that of glyceraldehyde 3-phosphate dehydrogenase 
(housekeeping gene), in the gingivae of mice was assessed using RT-PCR.  
Differences in expression of maxillary MMP-9 mRNA in mice groups (n = 5 per group) were 
determined by ANOVA with post hoc Tukey-Kramer testing (InStat version 3.10; GraphPad 
Inc., San Diego California USA).  








Figure 3.9 – Cannabidiol did not affect the expression of MIP-2 in different treatment groups.  
 
Expression of MIP-2 mRNA, relative to that of glyceraldehyde 3-phosphate dehydrogenase 
(housekeeping gene), in the gingivae of mice was assessed using RT-PCR.  
Differences in expression of maxillary MIP-2 mRNA in mice groups (n = 5 per group) were 











10.  Cannabidiol did not affect the linear alveolar bone levels among different groups. 
 
              
Figure 3.10 – No significant difference was found in linear alveolar bone levels among different groups. 
 
Alveolar bone loss was measured in CB2-/- and Wild type mice, infected or not infected with 
P. gingivalis, in a baker model of Periodontitis at sacrifice. The distance between Cervical-
enamel junction and Alveolar bone crest was measured at 14 predetermined sites in maxilla. 
Measurements were taken by using micro CT.   
Differences in bone loss levels between mouse groups (n = 5 per group) were determined by 








11. Cannabidiol did not affect the bone mineral density values among different groups, 
analyzed by micro CT.   
 
           
Figure 3.11 - No significant difference was found in the bone mineral density values among 
different groups.  
 
Bone Mineral Density was measured in CB2-/- and Wild type mice, infected or not infected with 
P. gingivalis, in a baker model of Periodontitis at sacrifice. Mice heads were scanned using micro 
CT. The maxillary alveolar bone scanned images were reconstructed three dimensionally for 
assessment of bone mineral density. Maxillary first molar furcation area was chosen as region of 
interest for all the groups.  
Differences in bone mineral density between mouse groups (n = 5 per group) were determined by 





12. Cannabidiol did not affect the alveolar bone volume among different groups, analyzed 
by micro CT. 
 
            
Figure 3. 12 – Cannabidiol did not affect alveolar bone volume among different groups, analyzed my micro 
CT. 
 
Alveolar Bone Volume was measured in CB2-/- and wild type mice, infected or not infected with 
P. gingivalis, in a baker model of Periodontitis at sacrifice. Mice heads were scanned using micro 
CT. The maxillary alveolar bone scanned images were reconstructed three dimensionally for 
assessment of bone mineral density. Maxillary first molar furcation area was chosen as region of 
interest for all the groups.  
Differences in alveolar bone volume between mouse groups (n = 5 per group) were determined by 
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Periodontal disease is a highly prevalent, multifactorial, chronic inflammatory disease of 
periodontium eventually leading to destruction of supportive tissues of teeth and tooth loss.  
The interaction between microbes present in dental plaque and host immune response is a major 
determinant of progression and clinical manifestations of periodontal disease (Kaur, Grover, 
Bhaskar, Kaur, & Jain, 2018). P. gingivalis, a Gram-negative, black pigmented, assacharolytic 
and strict anaerobic bacteria, has long been considered an important member of the 
periodontopathic microbiota involved in periodontal disease progression and bone and tissue 
destruction (Holt, Kesavalu, Walker, & Genco, 1999). Apart from the periodontopathic 
microbiota, factors that suppress the immune system have been closely associated with chronic 
periodontitis. Cannabis is one such emerging risk factor that has been shown to contribute to 
chronic periodontitis as reported by human observational studies. Cannabidiol, one of the active 
components of cannabis is closely associated with immune cells and has been shown to exert 
immunosuppressive effects. Ineffective host immune response may lead to persistence of  
P. gingivalis in the host cells leading to increased alveolar bone loss through direct virulence 
factors of P. gingivalis.  
 
Experimental animal models have been used to understand the various mechanisms behind 
alveolar bone loss. Mice are the primary in-vivo model for human immune system function in 












Three-dimensional state of alveolar bone in the mouse model of periodontal infection has been 
assessed using micro computed tomography. Micro CT enables detection of intrabody defects 
and tissues all around the tooth. Due to the high accuracy and sensitivity resulting from the 3-
dimensional analysis of the micro-CT technique, fewer animals can be used to obtain significant 
results (Wilensky, Gabet, Yumoto, Houri-Haddad, & Shapira, 2005).  
 
In our study we selected furcation area of maxillary first molar as region of interest and 
determined bone volume and bone mineral density for each scanned and reconstructed maxillary 
bone. Twenty slices of each bone section were used to determine the values. Cannabidiol did not 
affect alveolar bone loss, alveolar bone volume and alveolar bone density.  
 
To monitor if cannabidiol alters the immune response in mice infected with P. gingivalis, we 
analyzed the production of antibodies in serum of mice in response to P. gingivalis and 
expression of inflammatory markers in maxillary gingiva of P. gingivalis infected mice in 
presence of cannabidiol. P. gingivalis induces strong antibody response (Kinane, Mooney, & 
Ebersole, 1999) and elevated levels of circulating antibodies  P. gingivalis in patients with 
periodontitis have been reported (Chung et al., 2003), (Graswinckel, van der Velden, van 
Winkelhoff, Hoek, & Loos, 2004). In large population of adults, who participated in the third US 
National Health and Nutrition Examination Survey, high titers of antibodies against P. gingivalis 
were consistently associated with periodontitis (Dye et al., 2009). In the present study, we 
examined association between the levels of P. gingivalis specific serum IgG and IgM; total IgG 
and IgM; and the mice infected or not infected with P. gingivalis. Cannabidiol significantly 
reduced the expression of total IgM antibodies in wild type infected with P. gingivalis, however 
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this response was not observed in knock-out mouse. CB2 -/-
 
mice infected with P. gingivalis 
showed higher levels of P. gingivalis specific serum IgG levels but not wild type mice. If this 
phenomenon were to happen in humans, it would mean that the adaptive immune response is not 
well equipped to respond to the challenge in presence of pathogen.   
 
We analyzed effect of cannabidiol on expression of inflammatory markers – CD45, CD14, 
MMP-9 and IL1β in the maxillary gingivae of mice. Inflammatory markers mediate the initial 
immune responses and are crucial for clearance of pathogen and hence resolution of 
inflammatory disease like chronic periodontitis.  
 
Mouse CD45 (leukocyte common antigen) causes increase in cytokine production and 
proliferation of T cells (Hermiston et al., 2003). CD45 isoforms are present on all nucleated 
hematopoietic cells. Since, it appears to play a significant role in the ability of immune cells to 
respond to activating stimuli (Donovan & Koretzky, 1993), we wanted to determine the effect of 
cannabidiol on expression of CD45 in maxillary gingivae of mice. In our experiment, 
cannabidiol significantly reduced the expression of CD45 in P. gingivalis infected wild type 
mice, however this effect was not observed in knock-out mice. Reduced expression of CD45 
would lead to insufficient cell mediated immunity to pathogen and hence its persistence.  
 
CD14 is expressed mainly by macrophages and neutrophils. It acts as a co receptor (along with 
TLR -4) for detection of bacterial polysaccharide (Kitchens, 2000). CD14 is expressed mainly by 
macrophages and (at 10-times lesser extent) by neutrophils. It is also expressed by dendritic cells 
(Funda et al., 2001). CD14 plays a pivotal role in TLR4 activation that in turn has a crucial role 
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in activation of innate immunity and pathogen recognition (Kirschning & Bauer, 2001). In our 
experiment, cannabidiol significantly reduced the expression of CD14 in wild type mice infected 
with P. gingivalis. This phenomenon was not seen in knock-out mice. Reduced expression of 
CD14 in response to pathogen would mean increased bacterial invasion and more severe tissue 
injury.  
 
Matrix Metalloproteinases (MMPs) are zinc-dependent endopeptidases that can cleave 
extracellular matrix (Basi et al., 2011). MMP-9 levels are increased during inflammatory 
conditions like periodontal diseases. Degradation of the extracellular matrix and basement 
membrane leads to the development of periodontitis (Desarda H, Gaikwad, 2012) (Yu & 
Stamenkovic, 2000).  High levels of MMP-9 was found in Gingival crevicular fluid in patients 
with the periodontitis (Rai, Kharb, Jain, & Anand, 2008). It is mainly released from osteoclasts 
and polymorphonuclear neutrophils in the periodontal tissues (Ertugrul, Dursun, Dundar, 
Avunduk, & Hakki, 2013).  Levels of MMP -9 levels were found higher in smokers who also had 
periodontitis as compared to non-smokers (He, Gao, & Jiang, 2016). In our experiment, 
cannabidiol significantly reduced the expression of MMP-9 in wild type mice infected with P. 
gingivalis. However, this effect was not seen in knock-out mice.  
 
IL-1β is a member of the proinflammatory IL-1 cytokine superfamily. IL-1 family cytokines are 
the considered ‘early-response’ cytokines that are released in the earliest stage of an immune 
response and act as a trigger for subsequent cascade of proinflammatory cytokines. IL-1β 
stimulates the release of IL-6 and IL-17a cytokines (Krishnan, Sobey, Latz, Mansell, & 
Drummond, 2014). In our experiment, cannabidiol significantly reduced the expression of  IL-1β 
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in the maxillary gingivae of wild-type mice infected with P. gingivalis, however this effect was 
not seen in knock-out mice. Downregulation of IL-1β may lead to ineffective innate and adaptive 
immune responses and hence persistence of pathogen.  
 
Macrophage inflammatory protein (MIP-2) in mice is a member of the alpha chemokine family 
which also includes human IL-8 (Wolpe et al., 1989). MIP-2 is expressed in epithelial cells after 
stimulation with Lipopolysaccharide or proinflammatory cytokines (Ohtsuka, Lee, Stamm, & 
Sanderson, 2001). As with IL-8 in humans, MIP-2 is chemotactic for neutrophils and induces 
localized neutrophil infiltration, thus regulating the inflammatory cells (Wolpe et al., 1988).  
In our experiment, cannabidiol did not affect the expression of MIP-2 in the groups of mice 
infected with P. gingivalis.  
 
Cannabidiol significantly reduced the expression of IL-1β, CD45 and CD14 inflammatory 
markers in maxillary gingiva in P. gingivalis infected wild type mice but not CB2 -/- mice. 
Deficient immune response to P. gingivalis may lead to its persistence and more severe 
periodontal destruction in cannabis users. This is analogous with in-vitro nicotine studies and 
with clinical studies showing more severe clinical manifestations of chronic periodontitis in 
tobacco smokers. However, our results showed a reduction in MMP-9 expression in presence of 
cannabidiol. This anomaly is hard to explain and does not correspond with the findings in 







Increased bone loss was hypothesized because we know cannabis drives bone loss in animals and 
humans. This did not happen here. May be because we didn’t have persistent infection. However, 
immune differences between wild type versus knock out mice that we did see could have a long-
term effect in chronic infection.  
 
In summary, cannabidiol alters the immune response to P. gingivalis in mice by affecting the 
secretion of immunoglobulins and expression of inflammatory markers. Suppression of immune 
response by cannabidiol can lead to increased periodontal destruction in presence of P. 
gingivalis. Although no difference in bone loss was found in this model, the effect on 
inflammatory mediators by cannabidiol was significant. This could have an impact on chronic 
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